STADA Pymepharco and Kim Do Pharmaceutical Establish Strategic Distribution Partnership to Expand Access to Quality Healthcare in Vietnam

Ho Chi Minh City, February 13, 2025 | STADA Pymepharco is pleased to announce the official launch of a strategic distribution partnership with Kim Do Pharmaceutical Co., Ltd., marking a significant milestone in the company’s long-term commitment to improving access to high-quality medicines across Vietnam.

This partnership is designed to expand the availability of pharmaceutical products that meet German quality standards through the hospital channel nationwide. It reflects a shared mission between the two companies to enhance healthcare delivery for patients, healthcare professionals, and consumers alike.

By combining STADA Pymepharco’s strong portfolio of high-quality, internationally aligned pharmaceuticals with Kim Do Pharmaceutical’s extensive distribution network, the partnership aims to ensure broader, more efficient, and sustainable access to essential medicines across the country.

Mr. Philippe Gautron, General Manager of STADA Pymepharco, remarked: “This partnership reinforces our commitment to strengthening the healthcare system in Vietnam through trusted collaboration and responsible growth. Together with Kim Do, we look forward to delivering greater value to patients and creating lasting positive impacts for the communities we serve”.

STADA Pymepharco extends our sincere appreciation to the leadership and team at Kim Do Pharmaceutical for their trust and partnership. Both companies are enthusiastic about the road ahead – one marked by collaboration, innovation, and shared dedication to advancing public health in Vietnam.